Ambiq Micro, Inc. AMBQ
44.68 USD +1.37 (+3.16%)
At closeNov 4, 2026, 4:00 AM EST
46.14 +1.46 +3.27%
Pre-market · Nov 4, 4:00 AM ET
44.65 Day range 46.39
22.12 52-week range 91.61
- YTD
- +56.77%
- 1 year
- +62.24%
Analyst view
Consensus: buy
Buy
Price target (mean) 84.43 +89.0% upside
Now 44.68
- Target (low)
- 50.00
- Target (mean)
- 84.43
- Target (high)
- 125.00
Ratings (0m) 7 5 buy · 2 hold · 0 sell
- Strong buy1
- Buy4
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.15808 | -0.16 – -0.15 | -0.22 | +28.1% | 36.60M | +101.5% | 7 |
| Next quarter | -0.06414 | -0.10 – -0.04 | -0.32 | +80.0% | 39.62M | +91.0% | 7 |
| Current year | -0.5375 | -0.58 – -0.50 | -2.62 | +79.5% | 135.20M | +86.5% | 7 |
| Next year | -0.21674 | -0.45 – -0.04 | -0.5375 | +59.7% | 178.43M | +32.0% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 7, 2026 | Jefferies | Initiated | — | Buy |
| Oct 5, 2026 | Stifel | Maintained | Buy | Buy |
| Aug 12, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 12, 2026 | Needham | Maintained | Buy | Buy |
| Jul 14, 2026 | Roth Capital | Initiated | — | Buy |
| May 13, 2026 | UBS | Maintained | Neutral | Neutral |
| May 12, 2026 | Needham | Maintained | Buy | Buy |
| May 4, 2026 | UBS | Maintained | Neutral | Neutral |
| Apr 21, 2026 | Northland Capital Markets | Initiated | — | Outperform |
| Oct 27, 2025 | UBS | Maintained | Neutral | Neutral |
| Aug 25, 2025 | Stifel | Initiated | — | Buy |
| Aug 25, 2025 | B of A Securities | Initiated | — | Neutral |
| Aug 25, 2025 | UBS | Initiated | — | Neutral |
| Aug 25, 2025 | Needham | Initiated | — | Buy |